Adamax
Also known as Adamax · N-acetyl Semax adamantane · Semax adamantyl analog
New
Reconstitution & dosing guide
10 mg vial — research phases, recon steps, and a live unit calculator.
Available sizes & price
Catalog only10mg x 10 vials
Adamax · Not in current stock
$60 / vial
Prices per vial · Research use only · Not medical advice.
Designer Semax analog featuring terminal modifications (acetylation ± adamantane-related) intended to improve stability and BBB penetration; almost no independent peer-reviewed identity.
How to picture it
A Semax-family cognitive concept with structural modifications aimed at stronger or longer nootropic signaling. Same "brain resilience and BDNF-adjacent" neighborhood as Semax, tuned for people following next-step analogs in the Russian nootropic tradition. Picture the neurotrophic memo idea with chemical tweaks for stability/handling.
Research focus & benefits
- Semax-family nootropic research interest
- BDNF-adjacent cognitive pathway studies
- Modified peptide stability concepts
Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.
Overview
Adamax is a vendor-defined cognitive peptide in the ACTH(4–10)/Semax family. Structural reports vary (N-acetyl Semax with adamantane-inspired termini is the common story). Essentially all mechanistic claims are extrapolated from Semax (BDNF upregulation, neuroprotection) rather than Adamax-specific RCTs.
Mechanism
Presumed Semax-like melanocortin/BDNF-pathway activity with chemical modifications aimed at longer half-life and better CNS delivery. Parent Semax has Russian clinical literature; Adamax does not.
Research uses
- Extrapolated from Semax BDNF and neuroprotection studies
- Designer nootropic analog chemistry
Research dosing notes
Community protocols mirror Semax (hundreds of mcg nasal). No validated dose. Treat as experimental Semax-class material.
Half-life / kinetics
Unknown (designed longer than Semax; unpublished PK)
Common research routes
Reported considerations
- Nasal irritation
- Head pressure
- Insomnia if late dosing
- Unknown unique risks
Contraindications / cautions
- Pregnancy
- Serious psychiatric disease needs standard care
Common research stacks
- Semax
- Selank
- P21
- PE-22-28
Legal / access note
No independent clinical approval. Designer research peptide; verify COA identity.